BioNTech SE
BNTX
$92.80
-$0.87-0.93%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -1.19% | 9.96% | 11.45% | 6.95% | 7.44% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -1.19% | 9.96% | 11.45% | 6.95% | 7.44% |
| Cost of Revenue | 13.85% | 14.08% | 19.84% | 17.34% | 26.88% |
| Gross Profit | -5.00% | 8.90% | 9.41% | 5.02% | 3.43% |
| SG&A Expenses | 40.23% | 19.85% | 9.58% | -9.56% | -11.02% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 233.36% | 44.96% | 39.21% | 316.83% | 346.40% |
| Total Operating Expenses | 31.31% | 12.57% | 9.02% | 17.86% | 18.93% |
| Operating Income | -149.49% | -18.06% | -3.81% | -93.57% | -94.56% |
| Income Before Tax | -334.21% | -60.00% | -58.69% | -69.83% | -61.72% |
| Income Tax Expenses | 240.74% | 433.61% | 796.32% | -64.47% | -117.38% |
| Earnings from Continuing Operations | -406.91% | -76.93% | -76.39% | -26.46% | 29.76% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -406.91% | -76.93% | -76.39% | -26.46% | 29.76% |
| EBIT | -149.49% | -18.06% | -3.81% | -93.57% | -94.56% |
| EBITDA | -161.13% | -12.86% | -3.14% | -84.48% | -118.59% |
| EPS Basic | -386.42% | -72.00% | -75.22% | -26.18% | 29.71% |
| Normalized Basic EPS | -393.85% | -62.27% | -79.61% | -117.96% | -70.28% |
| EPS Diluted | -382.25% | -71.31% | -74.42% | -24.80% | 29.88% |
| Normalized Diluted EPS | -389.96% | -61.70% | -78.83% | -112.02% | -65.19% |
| Average Basic Shares Outstanding | 2.69% | 1.61% | 0.24% | -0.09% | 0.36% |
| Average Diluted Shares Outstanding | 2.38% | 1.29% | -0.07% | -0.53% | 0.16% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |